AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) sold $1K-$15K of Regeneron Pharmaceuticals, Inc. (REGN) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a sale of Regeneron Pharmaceuticals, Inc. (REGN) stock worth $1K-$15K in a STOCK Act filing on Aug 9, 2021.
The trade happened on Jul 1, 2021, 39 days before it was made public.
REGN has moved +27.9% since the trade date, from $574.62 to $735.20 (Oct 2, 2026 close).
- Traded
- Jul 1, 2021
- Disclosed
- Aug 9, 2021
- Filing delay
- 39 days
- Price since
- +27.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (29)
- SellAAPL$1K-$15KAug 9, 2021
- BuyCOF$1K-$15KAug 9, 2021
- SellCTSH$1K-$15KAug 9, 2021
- BuyCTSH$1K-$15KAug 9, 2021
- SellDAVA$1K-$15KAug 9, 2021
- SellFIVE$1K-$15KAug 9, 2021
- SellIFNNY$1K-$15KAug 9, 2021
- SellLOPE$1K-$15KAug 9, 2021
- BuyLOW$1K-$15KAug 9, 2021
- SellMRNA$1K-$15KAug 9, 2021
- SellNVDA$1K-$15KAug 9, 2021
- BuyORCL$1K-$15KAug 9, 2021
- SellPINS$1K-$15KAug 9, 2021
- BuyPNGAY$1K-$15KAug 9, 2021
- BuyPYCR$1K-$15KAug 9, 2021
- SellQTS$1K-$15KAug 9, 2021
- BuyROK$1K-$15KAug 9, 2021
- SellROLL$1K-$15KAug 9, 2021
- SellSAM$1K-$15KAug 9, 2021
- BuySIVB$1K-$15KAug 9, 2021
More REGN insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.